logo
15:52 Jun 23

Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
18102.00
+878.00 (+5.10%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Neuland Laboratories Ltd. Financials

Neuland Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
18102.00
+878.00 (+5.10%)
15:52 Jun 23
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

28/100
Expensive Valuation

Technical

65/100
Technically Moderately Bullish

Strength

15

Weakness

4

Opportunity

1

Threats

0

19.41 %

ROE %

12.42 %

ROA %

283.71

EPS

1,453.02

BVPS

17.99 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
951.08 1191.2 1558.58 1476.84 2022.99
Operating Expenses +
808.45 919.35 1095.99 1153.57 1448.48
Raw Material
437.55 487.74 632.43 574.81 819.76
Increase Decrease in Cost
-15.41 -9.51 -55.14 12.83 -64.26
Other Manufacturing Expense
131.36 135.56 156.51 162.87 0
Employee Cost
182.47 201.79 257.06 272 341.14
Miscellaneous Expenses
72.48 103.77 105.13 131.06 351.84
Operating Profit
142.63 271.85 462.59 323.27 574.51
Other Income
2.08 9.75 12.54 20.51 30.17
Depreciation
49.04 52.78 59.7 65.55 91.74
Interest
13.5 13.07 14 8.3 23.95
Profit before tax and exceptio..
82.16 215.75 401.44 269.93 488.98
Exceptional Items
0 0 0 76.4 0
PBT
82.16 215.75 401.44 346.33 488.98
Provision for Taxation
18.34 52.23 101.36 86.22 124.98
Net Profit
63.82 163.52 300.08 260.11 364
NET Profit after MI
63.82 163.52 300.08 260.11 364
EPS
49.74 127.45 233.89 202.74 283.71
Operating Profit Margin (%)
15 22.82 29.68 21.89 28.4
Net Profit Margin (%)
6.71 13.73 19.25 17.61 17.99

Neuland Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: